2 news items
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
PLX
10 May 24
demonstrate non-inferiority to approved therapies; inability or unwillingness of medical investigators and institutional review boards to follow our
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
PLX
14 Mar 24
demonstrate non-inferiority to approved therapies; inability or unwillingness of medical investigators and institutional review boards to follow our
- Prev
- 1
- Next